Find out more about difficulties that can be encountered when running a #randomised controlled #trial. #12DaysOfResearch https://t.co/xGGcyuuySr https://t.co/njP6UzA4EN
Darganfyddwch fwy am yr anawsterau a gellir eu wynebu wrth redeg #treial a reolir ar hap. #12DiwrnodYmchwil https://t.co/xGGcyuMah1 https://t.co/uNLA2zAAlX
RT @NefynWilliams: Lessons learnt from a discontinued randomised controlled trial: adalimumab injection compared with placebo for patients…
RT @NefynWilliams: Lessons learnt from a discontinued randomised controlled trial: adalimumab injection compared with placebo for patients…
Lessons learnt from a discontinued randomised controlled trial: adalimumab injection compared with placebo for patients receiving physiotherapy treatment for sciatica (Subcutaneous Injection of Adalimumab Trial compared with Control: SCIATiC) https://t.co/
RT @MedicalEvidence: Lessons learnt from a discontinued RCT for an adalimumab injection compared with placebo for patients receiving physio…
Learning from what didn't work to improve future RCTs - new paper in #Trialsjournal discusses the challenges faced when developing a new treatment pathway for a RCT of adalimumab for people with sciatica, & why the trial was stopped early: https://t.co
Lessons learnt from a discontinued RCT for an adalimumab injection compared with placebo for patients receiving physiotherapy treatment for sciatica via #Trialsjournal: https://t.co/SoCSoUHwZG
RT @TobyOSmith: Valuable paper on why some trials don't get to their expected end. Paper highlights challenges in MSK trials & value of fea…
Valuable paper on why some trials don't get to their expected end. Paper highlights challenges in MSK trials & value of feasibility work. #trialsarenteasy https://t.co/GrxQCAckUN